Filters: Keyword is Anti-HIV Agents [Clear All Filters]
"Development and application of a genotypic AZT resistance assay: quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index." Journal of acquired immune deficiency syndromes (1999) 28, no. 3 (2001): 211-20. Abstract
"Characteristics of nausea reported by HIV-infected patients initiating combination antiretroviral regimens." Clinical nursing research 11, no. 1 (2002): 71-88. Abstract
"A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298)." AIDS research and human retroviruses 18, no. 10 (2002): 699-704. Abstract
"Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project." Journal of acquired immune deficiency syndromes (1999) 30, no. 3 (2002): 311-5. Abstract
"The place of prevention in HIV clinical care: a roundtable discussion." AIDS clinical care 14, no. 6 (2002): 49-53, 58.
"State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards." Medical care 40, no. 5 (2002): 429-41. Abstract
"Report on the XIV International AIDS Conference." AIDS clinical care 14, no. 9 (2002): 77-85.
"Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy." Journal of acquired immune deficiency syndromes (1999) 31, no. 1 (2002): 27-37. Abstract
"The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 11, no. 1 (2002): 66-74. Abstract
"Report from the Tenth Retrovirus Conference. Clinical trials in resource-poor settings." AIDS clinical care 15, no. 4 (2003): 31-2.
"Report from the Tenth Retrovirus Conference. Tuberculosis." AIDS clinical care 15, no. 4 (2003): 32.
"Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 36, no. 12 (2003): e162-4. Abstract
"Global health and university patents." Science (New York, N.Y.) 301, no. 5640 (2003): 1629.
"A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting." Journal of acquired immune deficiency syndromes (1999) 36, no. 4 (2004): 929-34. Abstract
"Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy." Statistics in medicine 23, no. 15 (2004): 2375-98. Abstract
"Disease progression in HIV-infected patients treated with stavudine vs. zidovudine." Journal of clinical epidemiology 57, no. 1 (2004): 89-97. Abstract
"Use of total lymphocyte count for monitoring response to antiretroviral therapy." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38, no. 2 (2004): 257-62. Abstract
"Substance use of disorders in HIV-infected patients: impact and new treatment strategies." Topics in HIV medicine : a publication of the International AIDS Society, USA 12, no. 3 (2004): 77-82. Abstract
"Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38 Suppl 5 (2004): S376-87. Abstract
"Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38 Suppl 5 (2004): S421-8. Abstract
"Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica." AIDS patient care and STDs 18, no. 5 (2004): 297-304. Abstract
"Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care." AIDS (London, England) 18, no. 16 (2004): 2185-9. Abstract
"Meeting report from the XV International AIDS Conference. Access in the developing world." AIDS clinical care 16, no. 9 (2004): 69-70.
"Meeting report from the XV International AIDS Conference. Adherence." AIDS clinical care 16, no. 9 (2004): 74-5.
"Effect of persistent moderate viremia on disease progression during HIV therapy." Journal of acquired immune deficiency syndromes (1999) 37, no. 1 (2004): 1147-54. Abstract
"A therapeutic HIV vaccine: how good is good enough?" Vaccine 22, no. 29-30 (2004): 4044-53. Abstract
"High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study." Women & health 42, no. 2 (2005): 71-88. Abstract
"Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients." Antiviral therapy 10, no. 1 (2005): 41-52. Abstract
"Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals." Clinical pharmacokinetics 44, no. 1 (2005): 99-109. Abstract
"Report from the 12th Retrovirus Conference. Tuberculosis." AIDS clinical care 17, no. 4 (2005): 40-1.
"Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8." The Journal of infectious diseases 191, no. 3 (2005): 324-32. Abstract
"The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy." Archives of internal medicine 165, no. 4 (2005): 416-23. Abstract
"A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care." Alcoholism, clinical and experimental research 29, no. 7 (2005): 1190-7. Abstract
"Evaluation of multiple failure time analyses of observational data in patients treated for HIV." HIV clinical trials 6, no. 2 (2005): 81-91. Abstract
"HIV drug resistance and HIV transmission risk behaviors among active injection drug users." Journal of acquired immune deficiency syndromes (1999) 40, no. 1 (2005): 106-9. Abstract
"Report from the 13th retrovirus conference. Antiretroviral therapy in resource-limited settings." AIDS clinical care 18, no. 4 (2006): 38.
"Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice." Journal of acquired immune deficiency syndromes (1999) 41, no. 5 (2006): 563-72. Abstract
"Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers." Journal of acquired immune deficiency syndromes (1999) 42, no. 4 (2006): 455-9. Abstract
"Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV." The Journal of antimicrobial chemotherapy 58, no. 6 (2006): 1299-302. Abstract
"Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S113-8. Abstract
"Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S142-8. Abstract
"HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S3-9. Abstract
"Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S48-53. Abstract
"Involving behavioral scientists, health care providers, and HIV-infected patients as collaborators in theory-based HIV prevention and antiretroviral adherence interventions." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S10-7. Abstract
"Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial." Journal of acquired immune deficiency syndromes (1999) 43 Suppl 1 (2006): S41-7. Abstract
"AIDS: the first 25 years." AIDS clinical care 18, no. 6 (2006): 53-4.
"Models for integrating buprenorphine therapy into the primary HIV care setting." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 42, no. 5 (2006): 716-21. Abstract
"Report from the XVI International AIDS Conference. Which antiretroviral regimen first? Data from CPCRA." AIDS clinical care 18, no. 11 (2006): 98-9.
"Discrete stochastic models for compliance analysis based on an AIDS Clinical Trial Group (ACTG) study." Biometrical journal. Biometrische Zeitschrift 49, no. 5 (2007): 731-41. Abstract
"Update in HIV care." Journal of general internal medicine 22, no. 2 (2007): 253-6.
